Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2025

Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2025 is organized by Select Biosciences and will be held from May 15 - 16, 2025 at Embassy Suites by Hilton Miami International Airport, Miami, Florida, United States of America.

Description:
SelectBIO Extracellular Vesicles (EVs) and Lipid Nanoparticles (LNPs) 2025 Conference, brings together researchers and industry participants from both academia and companies focusing on studying the biology of EVs and LNPs and focusing on the interface of these fields.

Presentations will explore the latest advances in the EVs field from the study of their biology to their potential as engineered drug delivery vehicles and therarapeutics (targeted delivery of biologics and small molecules).

Additionally, the use of LNPs -- already successfully deployed in the clinic as the Covid-19 vaccine -- as a platform for vaccine and therapy deployment will be the focus of this conference and companies developing LNPs present their research and frame it in the context of clinical utility.

The co-located concurrent track is The Space Summit 2025 and attendees receive Full Access to both tracks running concurrently for maximal scientific exchange and networking.

NCATS has already announced that they will be funding EV research projects in microgravity in low-earth orbit (LEO) and so the fields of EV-research and microgravity research are converging. An excellent opportunity for EV researchers at this conference to engage with LEO experts to discuss and advise on sending research projects into microgravity on-board the International Space Station (ISS) or some of the private space stations coming online soon as a pay-per-use platform for LEO experiments and manufacturing in microgravity environment.

Agenda Topics:

• Exosomes/Extracellular Vesicles (EVs): Biological Investigations of Cargo
• EVs as Platform for Drug Delivery: Biologics or Small Molecules
• Engineered EVs as a Platform for Therapeutics
• Modulation of the Immune Response by EVs
• Synthetic LNPs: Characteristics and Properties
• LNPs as a Platform for Vaccine and Therapeutic Development